Literature DB >> 23599679

American society of hematology.

Walter Alexander.   

Abstract

Drug therapies for multiple myeloma, mantle-cell lymphoma, and myelodysplastic syndromes.

Entities:  

Year:  2013        PMID： 23599679      PMCID： PMC3628179     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  2 in total

1.  Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

Authors:  Antonio Palumbo; Roman Hajek; Michel Delforge; Martin Kropff; Maria Teresa Petrucci; John Catalano; Heinz Gisslinger; Wiesław Wiktor-Jędrzejczak; Mamia Zodelava; Katja Weisel; Nicola Cascavilla; Genadi Iosava; Michele Cavo; Janusz Kloczko; Joan Bladé; Meral Beksac; Ivan Spicka; Torben Plesner; Joergen Radke; Christian Langer; Dina Ben Yehuda; Alessandro Corso; Lindsay Herbein; Zhinuan Yu; Jay Mei; Christian Jacques; Meletios A Dimopoulos
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

2.  Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

Authors:  Edward A Stadtmauer; Donna M Weber; Ruben Niesvizky; Andrew Belch; Miles H Prince; Jesús F San Miguel; Thierry Facon; Marta Olesnyckyj; Zhinuan Yu; Jerome B Zeldis; Robert D Knight; Meletios A Dimopoulos
Journal:  Eur J Haematol       Date:  2009-03-19       Impact factor: 2.997
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.